ABSTRACT
INTRODUCTION: Percutaneous endoscopic gastrostomy (PEG) is considered a safe and effective method for nutritional support in patients with malnutrition and swallowing impairment with an estimated survival of over two months. Some indications, such as advanced cognitive decline, contraindicate the technique. MATERIALS AND METHODS: All patients who underwent PEG placement between January 2001 and May 2019 were included. Clinical data, indication, complications, and mortality were retrospectively analyzed. RESULTS: A total of 648 patients (46.5% male, mean age 70±18.5 years) were included. The most common indications for PEG were advanced cognitive decline (31.5%) and cerebrovascular disease (18.8%). The mean follow-up was 12.07 months (IQR 3.27-34.73). 39.5% of patients experienced complications (systemic 17.9%, local 28.5%). The most frequent were bronchoaspiration (9.7%) and rupture/dysfunction (13.9%), respectively. The presence of early complications (HR 1.63 [1.20-2.21]) and age (HR 1.02 [1.01-1.02]) were associated with shorter survival time, while female sex was a protective factor (HR 0.78 [0.66-0.94]). CONCLUSIONS: PEG is not without complications, with 39.5% of patients experiencing them. Patients with advanced dementia, male sex, older age, and systemic complications have lower survival following PEG placement.
ABSTRACT
We present the case of a 38-year-old man with no previous medical history who went to the emergency department due to abdominal pain and diarrheal stools with blood of 24 hours of evolution. The patient reports consumption of anti-inflammatories the previous days due to back pain.
Subject(s)
Colitis, Ischemic , Colitis , Abdominal Pain/chemically induced , Adult , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Colitis/chemically induced , Colitis, Ischemic/chemically induced , Colitis, Ischemic/diagnostic imaging , Diarrhea/chemically induced , Humans , MaleABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Gastrointestinal Hemorrhage/chemically induced , Selective Serotonin Reuptake Inhibitors/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Gastroscopy/methods , Duodenal Ulcer/diagnostic imaging , Gastrointestinal Hemorrhage/complications , Selective Serotonin Reuptake Inhibitors/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Abdominal Pain/etiology , Duodenal Ulcer/surgery , Biopsy , Single-Balloon Enteroscopy/methods , Risk FactorsABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Crohn Disease/diagnosis , Intestinal Diseases, Parasitic/diagnosis , Liver Abscess, Amebic/diagnosis , Antiprotozoal Agents/therapeutic use , Colonoscopy , Crohn Disease/drug therapy , Diagnosis, Differential , Diagnostic Errors , Drainage/methods , Entamoeba/isolation & purification , Inflammatory Bowel Diseases/diagnosis , Intestinal Diseases, Parasitic/therapy , Liver Abscess, Amebic/therapy , Metronidazole/therapeutic use , Ultrasonography, InterventionalABSTRACT
No disponible
